Navigation Links
First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

utility and cost-effectiveness. The model design took into account disease modifying therapy (DMT) acquisition costs, state-specific MS-related medical costs and the cost of lost worker productivity.

The analysis found that the total cost per patient over the time horizon of a patient's lifetime for COPAXONE(R) was estimated to be 34.7 percent, 16.8 percent and 14.5 percent less than Rebif(R), Betaseron(R) and Avonex(R), respectively. Sensitivity analyses showed the results to be sensitive to changes in health state utilities, the percentage reduction in disease progression rates as measured by EDSS in the first two years of therapy used to estimate immunomodulatory therapy treatment effects, model time horizon and immunomodulatory therapy acquisition costs.

The authors of this study note that limitations included reliance on clinical trial data, no inclusion of cost and utilities associated with adverse events, assumptions surrounding the discontinuation and switching of therapies and estimation of clinical outcomes, lack of sufficient head-to-head clinical trials and clinical trial relapse rate criteria associated with this analysis.

About MS

MS is a chronic neurodegenerative inflammatory disease of the central nervous system with an overall prevalence rate of approximately 400,000 people. The annual cost of MS (in 1994 $US) is estimated to be between $6.8 and $13.6 billion, composed largely of indirect costs for formal/informal care and lost earnings. Previous research finds that costs associated with MS rise at an exponential rate with increasing MS disability levels.

About COPAXONE(R)

Current data suggest COPAXONE(R) is a selective MHC class II modulator. COPAXONE(R) is indicated for the reduction of the frequency of relapses in RRMS. The most common side effects of COPAXONE(R) are redness, pain, swelling, itching, a lump or an indentation at the site of injection, weakness, infection, pain, nausea, joint pain, anxiety,
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
(Date:1/23/2015)... ATLANTA , Jan. 23, 2015 More than a ... a quarter of those with private insurance, filled a prescription ... to a report in this week,s Morbidity and Mortality Weekly ... health care providers to treat moderate to severe pain.  They ...
(Date:1/23/2015)... available for sale, The Armor1 Ankle Roll Guard is a ... by cushioning the ankle from an inversion or "roll." ... of any shoe type and allows the user to ... against sprains. With customers in physical therapy, podiatry, and ...
(Date:1/23/2015)... MONMOUTH JUNCTION, N.J. , Jan. 23, 2015 ... immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber ... surgery patients, announced the receipt of $385,642, net ... approved participant of the Technology Business Tax Certificate ...
Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
... YORK, March 15, 2012 Reportlinker.com announces that ... its catalogue: Vaccines - ... http://www.reportlinker.com/p0796961/Vaccines---Top-10-Global-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This market research report package ... situation, trends and future outlook for vaccines in ...
... Brainlab wins coveted ,red dot award., Creative heads ... designs altogether to the international product competition. Feature by ... sought after red dot in product design. ... surgical navigation system for the brain and body features ...
Cached Medicine Technology:Vaccines - Top 10 Global Markets 2Brainlab Curve Wins Coveted Red Dot Award: Product Design 2012 2Brainlab Curve Wins Coveted Red Dot Award: Product Design 2012 3
(Date:1/23/2015)... Hastings and Hastings, a law firm in Arizona ... of legal representation client review requests for slip and fall ... rise in the number of slip and fall related accidents ... Valley. With that said, a large number of injury victims ... law firm. Hastings and Hastings is a personal injury firm ...
(Date:1/22/2015)... LunaDress, with its top dressmaking technologies, has ... the business is showing its latest designs of wedding dresses ... to the company’s CEO, all the fresh new products are ... discounts, up to 80% off. All the clothes from LunaDress ...
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in Glendale, ... Health Alliance (PPHA). The PPHA's passion for others' well-being ... NFL greats, treated for obstructive sleep apnea (OSA) has propelled ... cause in the valley. The most recent plans for an ...
(Date:1/22/2015)... 2015 Blue Cross and Blue Shield of ... what it means to “Live Fearless.” , The ... share their stories about how they or someone they know ... by living in the moment. By telling these types of ...
(Date:1/22/2015)... January 22, 2015 A new white ... experience and person-centeredness in the long-term care environment as ... across the continuum. The paper, “The Power of Person-Centeredness ... perspectives and practices of the patient, resident and family ...
Breaking Medicine News(10 mins):Health News:Hastings and Hastings Reports a Record Number of Client Review Requests for Slip and Fall Accidents in 2014 2Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3
... every reason to celebrate. But a heart filled with ... cancer therapies, a growing body of research shows. , ... still under development increase long-term risk of cardiovascular ... and assistant professor in the Department of Surgery at ...
... Once again The Gerontological Society of America is inviting ... the country,s largest multidisciplinary conference in the field ... 16th 20th, 2007 at the Hilton San Francisco. ... year,s theme is "The Era of Global Aging: Challenges ...
... prostate and breast cancer development may also be behind ... the Kimmel Cancer Center at Jefferson in Philadelphia have ... the brakes on a cancer-causing gene is missing ... work is preliminary, the scientists say, the absent protein ...
... Aida,Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA), one of ... was granted an,additional patent related to its Rh-Apo2L ... been applied for which Aida believes places it ... was jointly,granted by China,s State Intellectual Property Office ...
... HH ) today announced the sale of Medicals ... Brandgold Ltd., a management buyout,group organized by Michael Benton, ... Following the terms of the transaction, $14 million ... Hooper Holmes when,the sale closed on October 9. Terms ...
... 11 You want to remove,some fat (cellulite) and ... surgery. The Aesthetic Plastic Surgery and Laser Center ... used together to accomplish,these goals -- without surgery. ... Michelle Hardaway, a prominent Farmington Hills plastic surgeon and,owner ...
Cached Medicine News:Health News:Breast cancer awareness calls for cardiovascular awareness 2Health News:Breast cancer awareness calls for cardiovascular awareness 3Health News:The era of global aging: GSA showcases cutting-edge San Francisco meeting topics 2Health News:The era of global aging: GSA showcases cutting-edge San Francisco meeting topics 3Health News:Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer 2Health News:Aida Granted Additional Anti-Cancer Patent 2Health News:Hooper Holmes Concludes Sale of Medicals Direct 2Health News:Prominent Farmington Plastic Surgeon Uses Two New Non-Surgical Procedures to Tighten Skin and Remove Fat 2
Inquire...
Specifically for placing follicular units....
... mm. In vivo results may be affected by ... Encapsulation scar tissue can impact the desired augment-ation ... vary from patient to patient. Implant dimensions can ... or surgical scissors. All dimensions in centimeters. This ...
... as an interactive data-gathering extension of the ... runs on your Windows-based PC to deliver ... in comparative diagnosis. Now you can download ... Workstation with the simple click of a ...
Medicine Products: